Professional Documents
Culture Documents
Metodol - Sobre Cultivo de Keratinocitos
Metodol - Sobre Cultivo de Keratinocitos
Abstract Introduction
Ether-à-go-go-1 (Eag1) potassium channels are potential tools Ether à go-go (EAG) potassium channels possess oncogenic
for detection and therapy of numerous cancers. Here, we properties (1); human Eag1 (hEag1) mRNA shows restricted
show human Eag1 (hEag1) regulation by cancer-associated distribution in healthy tissues expressed mainly in brain; slightly
factors. We studied hEag1 gene expression and its regulation in placenta, testis, and adrenal gland; and transiently in myoblasts
by estradiol, antiestrogens, and human papillomavirus (HPV) (1–3). Interestingly, Eag1 is abundantly expressed in tumor cells,
oncogenes (E6/E7). Primary cultures from normal placentas including cervical, lung, breast, colon, and prostate cancer (2, 4);
and cervical cancer tissues; tumor cell lines from cervix, cho- therefore, Eag1 is suggested as a cancer marker. In addition, an
riocarcinoma, keratinocytes, and lung; and normal cell lines association of Eag1 amplification with reduced overall survival has
from vascular endothelium, keratinocytes, and lung were used. been observed in patients with colon carcinoma (5). Inhibition of
Reverse transcription-PCR (RT-PCR) experiments and South- Eag1 gene expression decreases tumor cell proliferation (1, 6, 7),
ern blot analysis showed Eag1 expression in all of the cancer and inhibition of Eag1 channel activity by imipramine or
cell types, normal trophoblasts, and vascular endothelium, in astemizole has been suggested to decrease cancer cell proliferation
contrast to normal keratinocytes and lung cells. Estradiol and (6–8). Specific block of Eag1 with monoclonal antibodies inhibits
antiestrogens regulated Eag1 in a cell type–dependent manner. tumor cell growth both in vitro and in vivo (9). Thus, Eag1 is also
Real-time RT-PCR experiments in HeLa cells showed that suggested as a cancer therapeutic target. Because no obvious side
Eag1 estrogenic regulation was strongly associated with the effects were observed in the animals treated with monoclonal
expression of estrogen receptor-A. Eag1 protein was detected antibodies (9), the potential therapeutic value of Eag1 channels
by monoclonal antibodies in normal placenta and placental seems to be very high.
blood vessels. Patch-clamp recordings in normal trophoblasts High-risk human papillomavirus (HR-HPV) is the major risk
treated with estradiol exhibited potassium currents resembling factor for cervical cancer (10), and estrogen use is suggested as a
Eag1 channel activity. Eag1 gene expression in keratinocytes likely factor contributing to this cancer (11). Actually, estrogen
depended either on cellular immortalization or the presence receptors (ER) or aromatase enzymes provide advantages for
of HPV oncogenes. Eag1 protein was found in keratinocytes proliferation of tumor cells derived from mammary gland, lung,
transfected with E6/E7 HPV oncogenes. Cell proliferation of and cervix (12, 13). Nevertheless, tamoxifen stimulates proliferation
E6/E7 keratinocytes was decreased by Eag1 antibodies inhibit-
of some cancer cells (14–16).
ing channel activity and by the nonspecific Eag1 inhibitors We reported Eag1 expression in normal cervical samples from
imipramine and astemizole; the latter also increased apoptosis.
women with negative pap smears, including a patient with HPV
Our results propose novel oncogenic mechanisms of estrogen/
infection (4). In addition, Eag1 mRNA was detected in the tumor-
antiestrogen use and HPV infection. We also suggest Eag1 as
free mammary gland surrounding the breast carcinoma tissue (2),
an early indicator of cell proliferation leading to malignancies
in human diverticulitis (which has the potential to change into
and a therapeutic target at early stages of cellular hyper-
colonic cancer), and in crypt cells of a colon cancer mouse model
proliferation. [Cancer Res 2009;69(8):3300–7]
(5). These observations suggest Eag1 expression as an early sign
of cellular hyperproliferation.
Despite the potential clinical relevance of Eag1, its regulation
Note: L. Diaz and I. Ceja-Ochoa contributed equally to this work. by cancer etiologic factors is poorly understood. Here, we studied
Requests for reprints: Javier Camacho, Centro de Investigación y de Estudios
Avanzados del I.P.N., Pharmacology Section, Avenida Instituto Politécnico Nacional hEag1 expression and regulation by some cancer-associated
2508, Mexico D.F., Mexico 07360. Phone: 52-55-57473800, ext. 5416; Fax: 52-55- factors, namely, estrogens, antiestrogens, and HPV oncogenes in
53430106; E-mail: fcamacho@cinvestav.mx.
I2009 American Association for Cancer Research. normal and tumor cells. We studied cervical cancer cells obtained
doi:10.1158/0008-5472.CAN-08-2036 from primary cultures and cell lines from different histogenesis.
Cancer Res 2009; 69: (8). April 15, 2009 3300 www.aacrjournals.org
Potassium Channels and Cancer Risk Factors
‘‘La Raza,’’ following the local ethical considerations. Tissue was placed in
liquid nitrogen to obtain mRNA or fixed in paraformaldehyde for
immunochemistry. For cytotrophoblast culturing, tissue was washed with
saline solution and immediately processed. Neonatal foreskins from
patients registered at Hospital ‘‘Gabriel Mancera’’ were collected following
the local ethical considerations and used to obtain normal keratinocytes
primary cultures.
Cell culture and reagents. Cytotrophoblasts were isolated and cultured
as described (18, 19). Villous tissue was enzymatically dispersed;
cytotrophoblasts were separated on a Percoll gradient, plated in DMEM-
HG with 20% fetal bovine serum (FBS) and incubated at 37jC (95%
humidity and 5% CO2 atmosphere). Human chorionic gonadotrophin
hormone (hCG) concentration was measured with an immunoassay kit
(Immunometrics Ltd.). Human cervical cancer cells were obtained from
previously established primary cultures (4). Tumor cell lines (HeLa, SiHa,
CaSki, INBL, and C33A from cervix; JEG-3 and A-549 from choriocarcinoma
and lung, respectively), as well as bronchial epithelial cells (BEAS) and
human umbilical vascular endothelial cells (HUVEC) from normal lung and
umbilical cord, respectively, were obtained from American Type Culture
www.aacrjournals.org 3301 Cancer Res 2009; 69: (8). April 15, 2009
Cancer Research
as previously described and also confirmed by sequence (4). In all cases, EDTA buffer [0.01 mol/L (pH 8.0)] and boiled for antigen retrieval. Slides
filters were washed after 18 h of hybridization and exposed to X-ray films. were blocked for 2 h with levamisole and incubated in the presence of
Real-time PCR amplifications. SYBR Green real-time PCR was 1:50 anti-Eag1 antibody (Ifv001 single-chain antibody coupled with alkaline
performed with 1 AL of cDNA obtained as described above. SYBR Green phosphatase) for 2 h at room temperature. The slides were washed with
reaction was conducted using a QuantiTect SYBR Green PCR reagents kit TBS/Tween, and the specific staining reaction was completed by
(Qiagen) following the manufacturer’s instructions. The following primers incubating the slides in the presence of 5-bromo-4-chloro-3-indolyl
were used: 5¶-TGG TCC TGC TGG TGT GTG-3¶ ( forward), 5¶-ACA ACG AGG phosphate/nitroblue tetrazolium (Roche) in a buffer solution for 1 h at
AGA TGT AGA CAG-3¶ (reverse) for Eag1 (4) and 5¶-ACC CCC ACT GAA room temperature, protected from light, and observed as a dark blue-
AAA GAT GAG TAT-3¶ ( forward), 5¶-ATG ATG CTG CTT ACA TGT CTC violet staining. Sections were counterstained with eosin. Slides were
GAT-3¶ (reverse) for b2-microglobulin (used as constitutive gene and to observed with a Nikon Eclipse E600 microscope using a Nikon Plan Apo
analyze relative Eag1 expression). Data analysis was performed by the 10/0.45 objective lens. Images were acquired with a DMX1200 camera
2 DDCt method. and the Nikon ACT-1 acquisition software at room temperature.
Eag1 immunochemistry. Specific anti-Eag1 antibodies were kindly Keratinocytes expressing HPV oncoproteins (K-E6, K-E6/E7) were pro-
provided by Walter Stühmer and Luis Pardo (Max Planck Institute). This cessed in a very similar manner. After antigen retrieval with EDTA, slides
antibody has been validated and shown to be very specific; it does not were blocked with endogenous peroxidase and phospatase blocker (Dako)
bind to hErg channels and discriminates between Eag1 and Eag2 (9). With for 10 min and then incubated in the presence of 1:100 anti-Eag1 antibody
this antibody, we already reported Eag1 channel expression in human for 1 h at room temperature. The slides were then incubated with MACH
cervical biopsies, cervical cancer cells from primary cultures, and CHO 4 mouse probe (Biocare) in TBS/Tween for 10 min and then incubated
cells transfected with Eag1 in opposite to the absence of Eag1 in with MACH 4 horseradish peroxidase polymer (Biocare) in TBS/Tween for
Cancer Res 2009; 69: (8). April 15, 2009 3302 www.aacrjournals.org
Potassium Channels and Cancer Risk Factors
Results
Regulation of Eag1 by Estradiol in Normal and Tumor
Cells
Eag1 channels in normal human placenta and vascular
endothelium and their regulation by estradiol. We investigated
www.aacrjournals.org 3303 Cancer Res 2009; 69: (8). April 15, 2009
Cancer Research
activation in the presence of extracellular magnesium (23). Figure cells (data not shown). In contrast, Eag1 was present in the lung
2D shows that outward currents elicited at +60 mV are slower cancer cell line A549 and up-regulated with most treatments,
when preceded by a very negative prepulse ( 140 mV) compared especially by antiestrogens (Table 1). Thus, E2 also regulates Eag1
with a more positive prepulse ( 60 mV), recordings were obtained expression in cancer cells in a cell type–dependent manner. Then,
in the presence of 10 mmol/L MgCl2. Because no other potassium we wondered whether a well-identified etiologic factor for some
channels have been reported to display such a strong Cole-Moore cancers could also affect Eag1 expression.
shift, our data suggest Eag1 channel activity in normal human
trophoblasts incubated with E2. Similar currents were elicited in Expression and Potential Role of Eag1 in Cells
the choriocarcinoma JEG-3 cells in the absence of estradiol (Fig. 2D, Expressing HPV Oncogenes
bottom), although, in this case, the current was not that accelerated Eag1 in cervical cancer cell lines and keratinocytes
with a more positive prepulse, as in normal human trophoblasts, expressing HPV oncogenes. We studied hEag1 gene expression
despite of a lower MgCl2 concentration (2 mmol/L) used. in normal keratinocytes and keratinocytes immortalized with the
Estrogenic regulation of Eag1 in cancer cells and the oncogenes E6, E7, or both (K-E6, K-E7, K-E6/E7), as well as in
participation of ERa. We studied estrogenic regulation of Eag1 immortalized keratinocytes lacking HPV and cervical cancer cell
in HeLa cells by real-time RT-PCR. We found Eag1 regulation by E2 lines presenting or lacking HR-HPV.
only at two-hormone concentrations (Fig. 3A) with no effect of the Normal keratinocytes did not express Eag1 (Fig. 4A); however, a
antiestrogens in these HeLa wild-type cells (Fig. 3A). ER-a mRNA prominent Eag1 expression was found in keratinocytes immortal-
Table 1. Relative Eag-1/cyclophilin expression in cancer cells treated with E2 and/or antiestrogens (from Southern blot
analysis)
Cell type E2 (10 nmol/L) E2 + ICI 182,780 E2 + Tx ICI 182,780 (100 nmol/L) Tx (100 nmol/L)
NOTE: Relative Eag-1/cyclophilin expression, in comparison with vehicle-treated cells which were given an arbitrary value of 1. Abbreviation: Tx,
tamoxifen.
Cancer Res 2009; 69: (8). April 15, 2009 3304 www.aacrjournals.org
Potassium Channels and Cancer Risk Factors
Placental development resembles malignant tumor behavior that Eag1 promotes vascular endothelial growth factor secretion
(17). We found Eag1 protein in the syncytiotrophoblast layer and and angiogenesis in tumors (29). The effect of other angiogenic
vascular endothelium of placental villi at the plasma membrane, in factors on Eag1 expression in both normal and cancer cells remains
the cytoplasm, and in the nucleus. This distribution was expected to be elucidated. We show the first recordings suggesting Eag1
because Eag1 has a bipartite nuclear targeting signal in its carboxy channel activity in normal human trophoblasts, but more
terminus (24) and perinuclear localization of Eag1 channels has pharmacologic studies are needed to determine the potential
been observed in tumors (2, 6). A COOH terminal fragment of a contribution of other potassium channels to the outward currents
voltage-gated calcium channel translocates to the nucleus and recorded in placental cells.
regulates transcription (25), a similar role for Eag1 remains elusive. Human ERa is necessary for a clear estrogenic regulation of Eag1
Eag1 mRNA was rarely detected in trophoblast primary cultures gene expression in HeLa cells. Only when forced to express ER-a did
despite cell viability confirmation by basal and 8-bromo-cyclic estradiol and antiestrogens clearly up-regulated Eag1. Actually, this
AMP–stimulated placenta hCG secretion (data not shown). is a potential explanation for the lack of estrogenic regulation of
Nevertheless, Eag1 mRNA expression was induced by E2. Chorio- Eag1 in JEG-3 cells, because these cells express very low amounts of
carcinoma JEG-3 cells displayed endogenous Eag1 gene expression; ER-a (30, 31). Thus, concerning ER-a expression, JEG-3 cells could be
however, Eag1 expression was only slightly regulated by estrogens compared with HeLa wild-type cells not transfected with ER-a.
and unaffected by ICI 182,780. Our results suggest that Eag1 might When screening estrogenic regulation of Eag1 mRNA in cells from
participate in the proliferation and/or fusion of trophoblast (as in cervical cancer primary cultures derived from three patients, we
myoblasts fusion; ref. 3), but this deserves further investigations. found similar effects in two cases but opposite effects in another
Eag1 protein was found in placental blood vessel endothelium, culture. Accordingly, tamoxifen opposite effects have been reported
accordingly; endogenous Eag1 mRNA was found in normal in cervical cancer. Tamoxifen treatment inhibited growth of cervical
HUVECs, up-regulated by E2 and down-regulated by ICI 182,780. cancer cell lines, including HeLa cells (32); but in the cervical cancer
This is important because estradiol is also considered as an cell line SFR lacking ERs, tamoxifen stimulated HPV-16 gene
angiogenic factor (26–28). Interestingly, it has been recently found expression and cell proliferation (16). Cervical cancer biopsies
www.aacrjournals.org 3305 Cancer Res 2009; 69: (8). April 15, 2009
Cancer Research
(16%) from patients treated with tamoxifen had a significant at early stages of cell hyperproliferation, for example, in cells initially
decrease in the number of mitotic figures (33). Thus, the variable transformed by HPV.
estrogenic regulation of Eag1 in cervical cancer primary cultures Eag1 channel activity is increased by arachidonic acid in IGR1
might have several explanations, including treatment conditions, melanoma cells (46), and insulin-like growth factor-I increases both
differences in HPV copy number, and different amounts of ERs or ER channel activity and gene expression of Eag1 in MCF-7 breast
phosphorylation; actually, tamoxifen can switch from ERa antago- cancer cells (47). Here, we show for the first time Eag regulation by
nist to ERa agonist if ERa is phosphorylated (34). cancer risk factors in normal cells. A highlighted feature in this
Estrogens stimulate growth and progression of lung tumors (35), study was that Eag1 can be regulated by both estrogens and HPV
and aromatase inhibitors suppress tumor growth in mice with oncoproteins. Eag1 up-regulation by E2 in HeLa cells and some
A-549 lung tumor xenografts (12). Eag1 was not found in BEAS-2B cervical cancer primary cultures suggest that estrogens and HPV
cells in accordance with the absence of Eag1 in normal bronchial might have a synergistic effect on Eag1 expression. Actually, it has
epithelium (2). We found Eag1 expression in A-549 cells in been shown that estrogens contribute to the onset, persistence,
compliance with the findings in lung cancer biopsies (2); in these and malignant progression of cervical cancer in a HPV-transgenic
cells, almost all treatments up-regulated Eag1. A combined therapy mouse model (48). A very interesting issue to address is to know
of antiestrogens and epidermal growth factor receptor (EGFR) the potential participation of Eag1 channels in the mouse cervical
inhibitor has been suggested for lung cancer (36) because of the cancer model mentioned. Another interesting issue is to investigate
functional linkage between estrogens and EGFRs (37). Therefore, the differential concentration-dependent effect of estrogens.
References myoblasts at the onset of fusion. FEBS Lett 1998;434: 6. DeQueiroz FM, Suarez-Kurtz G, Stühmer W, Pardo LA.
177–82. Ether à go-go potassium channel expression in soft
1. Pardo LA, Del Camino D, Sánchez A, et al. Oncogenic 4. Farias LMB, Ocaña DB, Dı́az L, et al. Ether à go-go tissue sarcoma patients. Mol Cancer 2006;5:42.
potential of EAG K+ channels. EMBO J 1999;18:5540–7. potassium channels as human cervical cancer markers. 7. Spitzner M, Ousingsawat J, Scheidt K, Kunzelmann K,
2. Hemmerlein B, Weseloh RM, DeQueiroz FM, et al. Cancer Res 2004;64:6996–7001. Schreiber R. Voltage-gated K+ channels support prolifer-
Overexpression of Eag1 potassium channels in clinical 5. Ousingsawat J, Spitzner M, Puntheeranurak S, et al. ation of colonic carcinoma cells. FASEB J 2007;21:35–44.
tumours. Mol Cancer 2006;5:41. Expression of voltage-gated potassium channels in 8. Gavrilova-Ruch O, Schönherr K, Gessner G, et al.
3. Occhiodoro TL, Bernheim L, Liu JH, et al. Cloning of a human and mouse colonic carcinoma. Clin Cancer Res Effects of imipramine on ion channels and proliferation
human ether-a-go-go potassium channel expressed in 2007;13:824–31. of IGR1 melanoma cells. J Membr Biol 2002;188:137–49.
Cancer Res 2009; 69: (8). April 15, 2009 3306 www.aacrjournals.org
Potassium Channels and Cancer Risk Factors
9. Gómez-Varela D, Zwick-Wallasch E, Knötgen H, et al. 23. Terlau H, Ludwig J, Steffan R, Pongs O, Stühmer W, non-small cell lung cancer shows enhanced antiprolifer-
Monoclonal antibody blockade of the human Eag1 Heinemann SH. Extracellular Mg2+ regulates activation ative effects. Cancer Res 2005;65:1459–70.
potassium channel function exerts antitumor activity. of rat eag potassium channel. Pflügers Arch Eur J 37. Levin ER. Bidirectional signaling between the estro-
Cancer Res 2007;67:7343–9. Physiol 1996;432:301–12. gen receptor and the epidermal growth factor receptor.
10. Walboomers JMM, Jacobs MV, Manos MM, et al. 24. Pardo LA, Contreras-Jurado C, Zientkowska M, Alves Mol Endocrinol 2003;17:309–17.
Human papillomavirus is a necessary cause of invasive F, Stühmer W. Role of voltage-gated potassium channels 38. zur Hausen H. Papillomaviruses and cancer: from
cervical cancer worldwide. J Pathol 1999;189:12–9. in cancer. J Membr Biol 2005;205:115–24. basic studies to clinical applications. Nat Rev Cancer
11. Moreno V, Bosch FX, Munoz N, et al. Effect of oral 25. Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, 2002;2:342–50.
contraceptives on risk of cervical cancer in women with Doltmesch R. The C terminus of the L-type voltage- 39. Aguilar-Lemarroy A, Kirchhoff S, Whitaker N, et al.
human papillomavirus infection: the IARC multicentric gated calcium channel Cav1.2 encodes a transcription Differential sensitivity of human papillomavirus type
case-control study. Lancet 2002;359:1085–92. factor. Cell 2006;127:591–606. 16(+) and type 18(+) cervical carcinoma cells to CD95-
12. Weinberg OK, Marquez-Garban DC, Fishbein M, et al. 26. Gagliardi C, Collins DC. Inhibition of angiogenesis by mediated apoptosis. Int J Cancer 2001;93:823–31.
Aromatase inhibitors in human lung cancer therapy. antiestrogens. Cancer Res 1993;53:533–5. 40. Scheffner M, Munger K, Byrne JC, Howley PM. The
Cancer Res 2005;65:11287–91. 27. Haran EF, Maretzek AF, Goldberg I, Horowitz A, state of the p53 and retinoblastoma genes in human
13. Nair HB, Luthra R, Kirma N, et al. Induction of Degani H. Tamoxifen enhances cell-death in implanted cervical-carcinoma cell-lines. Proc Natl Acad Sci U S A
aromatase expression in cervical carcinomas: effects of MCF7 breast-cancer by inhibiting endothelium growth. 1991;88:5523–7.
endogenous estrogen on cervical cancer cell prolifera- Cancer Res 1994;54:5511–4. 41. Lehman TA, Modali R, Boukamp P, et al. p53
tion. Cancer Res 2005;65:11164–73. 28. Dabrosin C, Palmer K, Muller WJ, Gauldie J. Estradiol mutations in human immortalized epithelial-cell lines.
14. Osipo C, Gajdos C, Liu H, Chen B, Jordan VC. promotes growth and angiogenesis in polyoma middle T Carcinogenesis 1993;14:833–9.
Paradoxical actions of fulvestrant in estradiol-induced transgenic mouse mammary tumor explants. Br Cancer 42. Suesbrich H, Waldegger S, Lang F, et al. Blockade of
regression of tamoxifen-stimulated breast cancer. J Natl Treat 2003;78:1–6. HERG channels expressed in Xenopus oocytes by the
Cancer Inst 2003;95:1597–608. 29. Downie BR, Sánchez A, Knotgen H, et al. Eag1 histamine receptor antagonists terfenadine and astemi-
15. Coiret G, Borowiec AS, Mariot P, Ouadid-Ahidouch H, expression interferes with hypoxia homeostasis and zole. FEBS Lett 1996;385:77–80.
Matifat F.The antiestrogen tamoxifen activates BK induces angiogenesis in tumors. J Biol Chem 2008;283: 43. Garcı́a-Ferreiro RE, Kerschensteiner D, Major F,
www.aacrjournals.org 3307 Cancer Res 2009; 69: (8). April 15, 2009